Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
GABA analogue |
| gptkbp:ATCCode |
gptkb:N03AX39
|
| gptkbp:CASNumber |
1351636-18-4
|
| gptkbp:developedBy |
gptkb:Pfizer
gptkb:UCB |
| https://www.w3.org/2000/01/rdf-schema#label |
darigabat
|
| gptkbp:intendedUse |
epilepsy
focal onset seizures |
| gptkbp:legalStatus |
investigational
|
| gptkbp:mechanismOfAction |
GABAA receptor positive allosteric modulator
|
| gptkbp:PubChem_CID |
71587761
CHEMBL4297626 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
CVL-865
PF-06372865 |
| gptkbp:UNII |
2Q1K1N2JZB
|
| gptkbp:bfsParent |
gptkb:Cerevel_Therapeutics
|
| gptkbp:bfsLayer |
6
|